Endocrine, Metabolic & Immune Disorders - Drug Targets(Formerly Current Dru

Possible Roles of Reg Family Proteins in Pancreatic Islet Cell Growth
pp. 1-10(10)
Authors: Liu, Jun-Li; Cui, Wei; Li, Bing; Lu, Yarong

The Use of Mycophenolate Mofetil for the Treatment of Systemic Sclerosis
pp. 11-14(4)
Authors: Shenin, Max; Naik, Manisha; Derk, Chris T.

Host-Pathogen Interactions in Latent Mycobacterium tuberculosis Infection: Identification of New Targets for Tuberculosis Intervention
pp. 15-29(15)
Authors: Lin, May Y.; Ottenhoff, Tom H.M.

The HIV-1 Rev Binding Family of Proteins: The Dog Proteins as a Study Model
pp. 30-46(17)
Authors: Panaro, Maria A.; Mitolo, Vincenzo; Cianciulli, Antonia; Cavallo, Pasqua; Mitolo, Carlo I.; Acquafredda, Angela

Distinct Functions of Retinoic Acid Receptor Beta Isoforms: Implications for Targeted Therapy
pp. 47-50(4)
Authors: Swift, Catherine B.; Hays, John L.; Petty, W. J.

G Protein Coupled Receptors as Drug Targets: The Role of β-Arrestins
pp. 51-61(11)
Authors: Dromey, Jasmin R.; Pfleger, Kevin D.G.

Monoclonal Antibodies: New Therapeutic Agents for Autoimmune Hemolytic Anemia?
pp. 62-68(7)
Authors: D'Arena, Giovanni; Taylor, Ronald P.; Cascavilla, Nicola; Lindorfer, Margaret A.

Epithelial-Mesenchymal Transition as a Therapeutic Target for Prevention of Ocular Tissue Fibrosis
pp. 69-76(8)
Authors: Saika, Shizuya; Yamanaka, Osamu; Flanders, Kathleen C.; Okada, Yuka; Miyamoto, Takeshi; Sumioka, Takayoshi; Shirai, Kumi; Kitano, Ai; Miyazaki, Ken-ichi; Tanaka, Sai-ichi